<table border="1" cellpadding="0" cellspacing="0" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="148.5pt"></col>
<col width="121.5pt"></col>
<col width="168.65pt"></col>
<tbody>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Concomitant Drug Name</content>
</paragraph>
</td>
<td stylecode="    Lrule     ">
<paragraph>
<content stylecode="bold">Effect of Carbamazepine on
  Other Drugs</content>
</paragraph>
</td>
<td stylecode="    Lrule     ">
<paragraph>
<content stylecode="bold">Clinical Recommendation</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     ">
<paragraph>Lithium</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>May increase the
  risk of neurotoxic side effects</paragraph>
</td>
<td rowspan="3" stylecode="     Toprule         Lrule     ">
<paragraph>Use
  with intensive monitoring</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     ">
<paragraph>Isoniazid</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>May increase
  isoniazid-induced hepatotoxicity</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     ">
<paragraph>Diuretics
  (e.g., hydrochlorothiazide, furosemide)</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>May
  lead to symptomatic hyponatremia</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     ">
<paragraph>Hormonal
  contraceptives (e.g., oral and levonorgestrel subdermal implant
  contraceptives)</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>May
  render the contraceptives less effective because the plasma concentrations of
  the hormones may be decreased; breakthrough bleeding and unintended
  pregnancies have been reported</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>Consider
  alternative or back-up methods of contraception</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     ">
<paragraph>Neuromuscular
  blocking agents (e.g., pancuronium, vecuronium, rocuronium, and cisatracurium)</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>Resistance to the
  neuromuscular blocking action of the non-depolarizing neuromuscular blocking
  agents</paragraph>
</td>
<td stylecode="     Toprule         Lrule     ">
<paragraph>Closely
  monitor patients for more rapid recovery from neuromuscular blockade than
  expected; infusion rate may need to be higher</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Toprule     "> Delavirdine or other non-nucleoside reverse transcriptase inhibitors (NNRTIs)</td>
<td stylecode="     Toprule         Lrule     "> Decrease in delavirdine or NNRTI levels</td>
<td stylecode="     Toprule         Lrule     "> Contraindicated with carbamazepine</td>
</tr>
</tbody>
</table>